Endothelin-1 regulates adiponectin gene expression and secretion in 3T3-L1 adipocytes via distinct signaling pathways

Endocrinology

Volumn 148, Issue 4, 2007, Pages 1835-1842

  Juan, Chi Chang ^a,b   Chuang, Tung Yueh ^a   Chang, Chih Ling ^a   Huang, Seng Wong ^a,b   Ho, Low Tone ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; PROTEIN KINASE C;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEMOSTASIS; IN VITRO STUDY; IN VIVO CULTURE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; INOSITOL PHOSPHATES; MICE; RECEPTOR, ENDOTHELIN A; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 33947364363     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0654     Document Type: Article

References (51)

1. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
3. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF 2000 Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1:81-88
4. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
5. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
6. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y 2001 Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133
7. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Haring H, Stumvoll M 2003 Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243
8. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF 2001 Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010
9. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
10. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE 2001 The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
11. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
12. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
13. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG 2000 Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 97:14478-14483
14. Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P 2000 Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480
15. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415
16. Sakamoto A, Yanagisawa M, Sakurai T, Takuwa Y, Yanagisawa H, Masaki T 1991 Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun 178:656-663
17. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T 1990 Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735
18. Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, De Mattia G 1995 Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 44:431-436
19. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR 1990 Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33:306-310
20. Ferri C, Bellini C, Desideri G, Baldoncini R, De Siati L, Santucci A 1997 Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalities. Diabetologia 40:100-102
21. Hauner H, Petruschke T, Gries FA 1994 Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells. Metabolism 43:227-232
22. Shinohara O, Murata Y, Shimizu M 1992 Endothelin-1 suppression of rat adipocyte precursor cell differentiation in serum-free culture. Endocrinology 130:2031-2036
23. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S 1990 Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732
24. Danthuluri NR, Brock TA 1990 Endothelin receptor-coupling mechanisms in vascular smooth muscle: a role for protein kinase C. J Pharmacol Exp Ther 254:393-399
25. el-Mowafy AM, Abdel-Latif AA 1994 Characterization of iris sphincter smooth muscle endothelin receptor subtypes which are coupled to cyclic AMP formation and polyphosphoinositide hydrolysis. J Pharmacol Exp Ther 268:1343-1351
26. Resink TJ, Scott-Burden T, Buhler FR 1990 Activation of multiple signal transduction pathways by endothelin in cultured human vascular smooth muscle cells. Eur J Biochem 189:415-421
27. May JS, Prince AM, Lyle RE, McGehee Jr RE 2001 Antisense suppression of p107 inhibits 3T3-L1 adipocyte differentiation. Biochem Biophys ResCommun 283:837-842
28. Green H, Kehinde O 1975 An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19-27
29. Juan CC, Fang VS, Hsu YP, Huang YJ, Hsia DB, Yu PC, Kwok CF, Ho LT 1998 Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model. J Hypertens 16:1775-1782
30. Clarke KJ, Zhong Q, Schwartz DD, Coleman ES, Kemppainen RJ, Judd RL 2003 Regulation of adiponectin secretion by endothelin-1. Biochem Biophys Res Commun 312:945-949
31. Stojilkovic SS, Balla T, Fukuda S, Cesnjaj M, Merelli F, Krsmanovic LZ, Catt KJ 1992 Endothelin ETA receptors mediate the signaling and secretory actions of endothelins in pituitary gonadotrophs. Endocrinology 130:465-474
32. Bedi D, Clarke KJ, Dennis JC, Zhong Q, Brunson BL, Morrison EE, Judd RL 2006 Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Biochem Biophys Res Commun 345:332-339
33. Roden M, Vierhapper H, Liener K, Waldhausl W 1992 Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver. Metabolism 41:290-295
34. Yang XY, Fekete Z, Gardner J, Benevenia J, Aviv A 1994 Endothelin mobilizes calcium and enhances glucose uptake in cultured human skeletal myoblasts and L6 myotubes. Hypertension 23:1075-1081
35. Usui I, Imamura T, Babendure JL, Satoh H, Lu JC, Hupfeld CJ, Olefsky JM 200) G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol 19:2760-2768
36. Lee YC, Juan CC, Fang VS, Hsu YP, Lin SH, Kwok CF, Ho LT 1998 Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors. Metabolism 47:1468-1471
37. Juan CC, Fang VS, Huang YJ, Kwok CF, Hsu YP, Ho LT 1996 Endothelin-1 induces insulin resistance in conscious rats. Biochem Biophys Res Commun 227:694-699
38. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G 1997 Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 161:211-220
39. Wilkes JJ, Hevener A, Olefsky J 2003 Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes 52:1904-1909
40. Juan CC, Chang CL, Lai YH, Ho LT 2005 Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 288:E1146-E1152
41. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865
42. Satoh H, Nguyen MT, Trujillo M, Imamura T, Usui I, Scherer PE, Olefsky JM 2005 Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats. Diabetes 54:1304-1313
43. Fu Y, Luo N, Klein RL, Garvey WT 2005 Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46:1369-1379
44. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K 2004 Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389
45. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y 2002 Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770
46. Ishida F, Saeki K, Saeki T, Ishikawa K, Ihara M, Kamei T, Yano M 1992 Suppressive effects of the endothelin receptor (ETA) antagonist BQ-123 on ET-1-induced reduction of lipoprotein lipase activity in 3T3-L1 adipocytes. Biochem Pharmacol 44:1431-1436
47. Xiong Y, Tanaka H, Richardson JA, Williams SC, Slaughter CA, Nakamura M, Chen JL, Yanagisawa M 2001 Endothelin-1 stimulates leptin production in adipocytes. J Biol Chem 276:28471-28477
48. Zhong Q, Lin CY, Clarke KJ, Kemppainen RJ, Schwartz DD, Judd RL 2002 Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 296:383-387
49. Prusty D, Park BH, Davis KE, Farmer SR 2002 Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor γ (PPARγ) and C/EBPα gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226-46232
50. Sale EM, Atkinson PG, Sale GJ 1995 Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 14:674-684
51. Bost F, Aouadi M, Caron L, Binetruy B 2005 The role of MAPKs in adipocyte differentiation and obesity. Biochimie (Paris) 87:51-56